GE Medical Imactis CT-Navigation System Recall - Discordant Needle Trajectory
Summary
FDA announced Class II recall of GE Medical Systems' Imactis CT-Navigation System due to potential discordance between simulated and actual needle trajectory/tip position. The recall affects Model Numbers E85101LA and E85101LP distributed nationwide. Healthcare providers using these systems should review and follow manufacturer's corrective instructions.
What changed
GE Medical Systems, LLC initiated a Class II recall of the Imactis CT-Navigation System (Model Numbers E85101LA and E85101LP) due to a potential issue that can lead to discordance between the simulated needle trajectory/tip position and the actual needle trajectory/tip position during CT-guided procedures. The recall is classified as ongoing and affects devices distributed nationwide in the United States.
Healthcare providers and facilities that have these specific Imactis CT-Navigation System models in use should immediately identify affected devices, contact GE Medical Systems for corrective instructions, review any recent procedures where the system was used, and report any adverse events or patient injuries related to this issue to FDA through MedWatch. Medical device distributors should also verify their inventory and communicate recall information to end-users.
What to do next
- Identify all Imactis CT-Navigation System units (Model E85101LA and E85101LP) in your facility inventory
- Contact GE Medical Systems for corrective instructions and follow recall remediation procedures
- Review patient records for procedures using affected devices and assess potential impact; report any adverse events to FDA via MedWatch
Source document (simplified)
GE Medical Systems, LLC
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1590-2026 · 20260401 · Ongoing
Product
Imactis CT-Navigation System, stereotaxic accessory for Computer Tomography (CT), systems, Model Numbers E85101LA and E85101LP
Reason for Recall
There is a potential issue that can lead to discordance between the simulated needle trajectory/tip position and the actual needle trajectory/tip position.
Distribution
Worldwide distribution - US Nationwide.
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.